ShareValue.ai

ShareValue scores for VIMTALABS.NSE: Valuation 50, Quality 68, Growth 48, Health 58.

VIMTALABS.NSE
NSE

Vimta Labs Limited

₹586.65(+0.58%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
50
Fair Value
Price vs Value
Quality
68
Moderate
Business Strength
Growth
48
Moderate
Revenue & Earnings
Health
58
Moderate
Financial Stability
Momentum
60
Bullish
Price Trend

Company Details

About

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.

Score Analysis

AI Investment Thesis

Data as of:Jul 3, 2026
|
Last calculated:Jul 3, 2026